Greetings. I am Tae-Myung Kim running as CEO in GB Lifecare.

GB Lifecare began as a specialized technical consulting group focused on research and development. Since our establishment in 2019, we have continuously developed glucose meters for the global market, distinguishing ourselves through technical expertise and rigorous quality control. Our dedication and passion for the healthcare industry have propelled us to grow into a leading global healthcare company.

The healthcare industry is undergoing a rapid transformation from a hospital-centered care system to a patient-centered one. With the paradigm shifting from disease treatment to disease prevention and management, the market demands innovative product development aligned with these changes.

Due to the rise in life expectancy, diabetes has become a condition that requires continuous management. GB Lifecare offers a smartphone-compatible glucose meter, along with a glucose management app designed for everyday use. In addition, the company provides services that support daily life management. As a specialist in blood glucose meters, we leverage our extensive knowledge of the diabetes market to develop a comprehensive diabetes care system. This system includes a GDH enzyme-based blood glucose meter, a digital insulin pen, and a non-invasive glucose meter. As pioneers in the medical IT field, we are also creating a point-of-care testing system that integrates with smartphones. This innovative approach will allow us to deliver an easy-to-use healthcare management system for our customers.

GB Lifecare remains dedicated to advancing technical expertise and growing as a global U-health company, delivering innovative products and services tailored to our customers' needs.

Thank you.